Physician profile
Christopher C Allen
NPI 1548242449
$7,359.94
in general payments reported to CMS, 2019-2025
25 companies · $2,473 in 2025
The $2,473 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,318 · 2020: $1,235 · 2021: $775 · 2022: $46.78 · 2023: $235 · 2024: $1,277 · 2025: $2,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,839 · Travel and Lodging: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,839.32 |
| Travel and Lodging | $1,145.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,859.76 | 2019-2025 | Impella |
| Medtronic, INC. | $1,335.78 | 2021-2025 | Advisa Dr Mri Surescan, Selectsecure, Tyrx |
| Abbott Laboratories | $1,198.57 | 2020-2023 | Mitraclip |
| Boston Scientific Corporation | $1,115.58 | 2019-2025 | Watchman Flx, Avvigo Guidance System, General - Balloon Catheters |
| Edwards Lifesciences Corporation | $218.36 | 2020-2024 | |
| Inari Medical, INC. | $195.04 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $168.29 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $142.48 | 2021 | |
| Cathworks, INC. | $112.24 | 2024 | Ffrangio |
| Medtronic Vascular, INC. | $111.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $103.85 | 2019-2025 | |
| Astellas Pharma US INC | $99.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $91.15 | 2019-2023 | Xarelto |
| Pfizer INC. | $90.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $86.01 | 2022-2023 | Verquvo, Belsomra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $77.70 | 2020-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $63.70 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $63.30 | 2020-2025 | Eliquis |
| Irhythm Technologies, INC. | $58.77 | 2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $49.92 | 2023-2024 | (Ck4) Mcot |
| Nalu Medical, INC. | $40.06 | 2025 | Nalu Neurostimulation System |
| Cordis US Corp. | $28.35 | 2023 | Mynxgrip |
| Sanofi-Aventis U.S. LLC | $21.50 | 2024 | |
| Cook Medical LLC | $15.87 | 2023 | Advance |
| W. L. Gore & Associates, INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.